Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of a Novel Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules

NCT04211051 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04211051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of a Novel Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 15, 2020
Completion date
October 21, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms